Moors & Cabot Inc. Takes Position in Church & Dwight Co., Inc. (NYSE:CHD)

Moors & Cabot Inc. acquired a new position in Church & Dwight Co., Inc. (NYSE:CHD) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 3,137 shares of the company’s stock, valued at approximately $329,000.

Several other large investors also recently added to or reduced their stakes in the business. Capital Performance Advisors LLP purchased a new position in shares of Church & Dwight during the 3rd quarter worth $27,000. Ashton Thomas Securities LLC bought a new position in Church & Dwight in the 3rd quarter worth $28,000. Rothschild Investment LLC purchased a new position in Church & Dwight during the second quarter valued at $31,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in Church & Dwight during the second quarter valued at about $33,000. Finally, Kimelman & Baird LLC purchased a new stake in Church & Dwight in the second quarter worth about $46,000. 86.60% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on CHD shares. Barclays cut their price objective on Church & Dwight from $86.00 to $85.00 and set an “underweight” rating for the company in a research note on Tuesday, November 5th. Morgan Stanley cut Church & Dwight from an “overweight” rating to an “equal weight” rating and set a $110.00 target price for the company. in a research report on Monday, September 9th. Wells Fargo & Company upped their price target on Church & Dwight from $113.00 to $115.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. Piper Sandler began coverage on shares of Church & Dwight in a research report on Tuesday, September 24th. They set an “overweight” rating and a $120.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Church & Dwight from $114.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, Church & Dwight has a consensus rating of “Hold” and a consensus target price of $108.53.

Insider Buying and Selling

In other news, EVP Maynadier Patrick D. De sold 45,120 shares of the company’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $112.19, for a total value of $5,062,012.80. Following the transaction, the executive vice president now directly owns 10,325 shares in the company, valued at approximately $1,158,361.75. This represents a 81.38 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Matthew Farrell sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $103.84, for a total transaction of $31,152,000.00. Following the completion of the transaction, the chief executive officer now directly owns 112,719 shares in the company, valued at $11,704,740.96. This represents a 72.69 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 535,733 shares of company stock valued at $55,920,470 in the last ninety days. 2.00% of the stock is owned by company insiders.

Church & Dwight Trading Down 0.3 %

Shares of CHD stock opened at $111.90 on Friday. The company has a market cap of $27.42 billion, a PE ratio of 50.18, a price-to-earnings-growth ratio of 4.11 and a beta of 0.55. Church & Dwight Co., Inc. has a 1 year low of $90.26 and a 1 year high of $113.50. The stock’s 50 day simple moving average is $104.17 and its two-hundred day simple moving average is $104.22. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.62 and a quick ratio of 1.09.

Church & Dwight (NYSE:CHD) last released its quarterly earnings results on Friday, November 1st. The company reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.68 by $0.11. The company had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.50 billion. Church & Dwight had a return on equity of 19.90% and a net margin of 9.08%. Church & Dwight’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.74 EPS. Research analysts predict that Church & Dwight Co., Inc. will post 3.45 earnings per share for the current year.

Church & Dwight Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Friday, November 15th will be issued a dividend of $0.2838 per share. The ex-dividend date is Friday, November 15th. This represents a $1.14 annualized dividend and a yield of 1.01%. Church & Dwight’s payout ratio is 50.67%.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.